5-Aminolevulinic acid combined with ferrous iron ameliorate ischemia-reperfusion injury in the mouse fatty liver model.

[1]  Xiao‐Kang Li,et al.  5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction. , 2016, International immunopharmacology.

[2]  G. Szabo,et al.  Inflammasome activation and function in liver disease , 2015, Nature Reviews Gastroenterology &Hepatology.

[3]  P. Zhu,et al.  5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway. , 2015, American journal of physiology. Cell physiology.

[4]  C. Byrne,et al.  NAFLD: a multisystem disease. , 2015, Journal of hepatology.

[5]  M. Nakajima,et al.  5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  P. Mandal,et al.  Protective role of HO-1 and carbon monoxide in ethanol-induced hepatocyte cell death and liver injury in mice. , 2014, Journal of hepatology.

[7]  M. Nakajima,et al.  5-Aminolevulinic acid combined with ferrous iron enhances the expression of heme oxygenase-1. , 2014, International immunopharmacology.

[8]  Xiao‐Kang Li,et al.  5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury. , 2013, American journal of physiology. Renal physiology.

[9]  G. Targher,et al.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis , 2013, Nature Reviews Gastroenterology &Hepatology.

[10]  P. Kubes,et al.  Sterile inflammation in the liver. , 2012, Gastroenterology.

[11]  Philipp Dutkowski,et al.  Liver transplantation using fatty livers: always feasible? , 2011, Journal of hepatology.

[12]  M. Büchler,et al.  Glycine and Taurine Equally Prevent Fatty Livers from Kupffer Cell‐Dependent Injury: An In Vivo Microscopy Study , 2011, Microcirculation.

[13]  M. Trauner,et al.  Fatty liver and lipotoxicity. , 2010, Biochimica et biophysica acta.

[14]  Y. Nakayama,et al.  Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[15]  T. Sugiyama,et al.  Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. , 2009, Journal of hepatology.

[16]  J. Rodés,et al.  Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury. , 2009, Endocrinology.

[17]  S. Hand,et al.  Mitochondria in energy-limited states: mechanisms that blunt the signaling of cell death , 2008, Journal of Experimental Biology.

[18]  R. McCuskey,et al.  Hepatic Microcirculation in Fatty Liver Disease , 2008, Anatomical record.

[19]  S. Sassa.  [Gene regulation by free heme]. , 2007, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[20]  Tatiana P. Dutra,et al.  Heme Induces Neutrophil Migration and Reactive Oxygen Species Generation through Signaling Pathways Characteristic of Chemotactic Receptors* , 2007, Journal of Biological Chemistry.

[21]  G. Gores,et al.  Apoptosis and necrosis in the liver: A tale of two deaths? , 2006, Hepatology.

[22]  M. Lotze,et al.  Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells1 , 2005, The Journal of Immunology.

[23]  G. Gores,et al.  Apoptosis: a mechanism of acute and chronic liver injury , 2005, Gut.

[24]  J Zaky,et al.  Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. , 1999, The Journal of clinical investigation.

[25]  N. Ohkohchi,et al.  Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis. , 1997, Transplantation proceedings.

[26]  R. Mason,et al.  Role of Kupffer cells in the pathogenesis of hepatic reperfusion injury. , 1994, The American journal of physiology.

[27]  M. Clouse,et al.  Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. , 1993, Transplantation.

[28]  Han‐Chieh Lin,et al.  Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury. , 2014, Clinical science.

[29]  J. Hughes,et al.  Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  Hartmut Jaeschke,et al.  Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[31]  H. Rüdiger,et al.  Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. , 2002, Gastroenterology.

[32]  P A Clavien,et al.  Fatty Liver in Liver Transplantation and Surgery , 2001, Seminars in liver disease.

[33]  A. Seifalian,et al.  In vivo demonstration of impaired microcirculation in steatotic human liver grafts. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.